Genetics & Stem Cells News

Medindia's Press Release’ section provides the latest press release on Genetics & Stem Cells from across the world for the global audience. This page links to 1809 Genetics & Stem Cells press releases.

SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers

SINGAPORE , May 12, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its ...


Medical College of Wisconsin Cancer Center leads groundbreaking change in Medicare policy for MDS patients over 65 in need of lifesaving transplants

MILWAUKEE , May 8, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell transplants (HCT) for eligible Medicare patients with ...

BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024

- Presentation Today, Monday, May 6, 2024 in Atlanta , Georgia  - TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing ...

Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing

The North Carolina -based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions RESEARCH TRIANGLE PARK, N.C. and WALTHAM, Mass. , April 25, 2024 /PRNewswire/ -- RTI International ...

GeneVentiv Therapeutics Awarded $2.5 Million SBIR Grant to Advance Gene Therapy for All Hemophilias, with or without Inhibitors

Damon R. Race , President & CEO RALEIGH, N.C. , April 16, 2024 /PRNewswire/ -- GeneVentiv Therapeutics, developer of GENV-HEM (AAV8.FVa) for all hemophilias, announced today it has been awarded a Direct to Phase II Small Business ...

First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH

SHANGHAI , April 2, 2024 /PRNewswire/ -- YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being developed as a single dose, potentially curative therapy ...

Vertex Announces New Drug Submission for Exagamglogene Autotemcel (exa-cel) Has Been Accepted for Priority Review by Health Canada for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

-Exa-cel is the first CRISPR-based gene-edited therapy to be submitted for Health Canada review- TORONTO , April 1, 2024 /CNW/ - Vertex Pharmaceuticals Incorporated  (Nasdaq: VRTX) today announced its New Drug Submission (NDS) for ...

Andelyn Biosciences and Grace Science, LLC Partner to Tech Transfer Phase I/II/III Manufacturing of a Suspension Process Adeno-Associated Virus (AAV) Gene Therapy for NGLY1 Deficiency

COLUMBUS, Ohio , March 25, 2024 /PRNewswire/ --  Andelyn Biosciences , Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Grace Science, LLC, to ...

Fluent Biosciences announces early access availability of transformative direct-guide capture for single cell analysis for complex CRISPR screening in Particle-templated Instant Partitions (PIPseq-CRISPR)

WATERTOWN, Mass. , March 21, 2024 /PRNewswire/ -- Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces early access availability of new kits and reagents ...

MARCH 21 - WORLD DOWN SYNDROME DAY "ASSUME THAT I CAN"

For World Down Syndrome Day, the Canadian Down Syndrome Society and CoorDown presents " ASSUME THAT I CAN" an international awareness campaign to #EndTheStereotypes . TORONTO , March 18, 2024 /CNW/ - For World Down Syndrome Day on ...

Genetics & Stem Cells News »

Guiding Precision Therapies for Seizures

Guiding Precision Therapies for Seizures

Alterations in the SCN2A gene influence the age of seizure onset and the severity of neurological impairments in affected children, aiding in the identification of suitable candidates for precision medicines and gene therapies in clinical trials , as ...

CRISPR's Molecular Mechanisms for Antibiotic Resistance

CRISPR's Molecular Mechanisms for Antibiotic Resistance

Assistant Prof. Ibrahim, Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic presents a research review elucidating CRISPR's molecular biology and its potential in addressing antimicrobial ...

Genetic Blueprint for Longevity

Genetic Blueprint for Longevity

Genetic predisposition towards greater muscle strength is associated with a longer lifespan and reduced vulnerability to common diseases, based on analysis of health and genome...

Stem Cell Therapy in Spinal Cord Injury Rehabilitation

Stem Cell Therapy in Spinal Cord Injury Rehabilitation

Stem cell therapy emerges as a viable and safe choice for individuals grappling with challenging traumatic spinal cord injuries , said experts ( ). Stem Cell Therapy’s Safety and Promising Benefits "This study documents the safety and ...

Over 275 Million Genetic Variants Unlock the Key to Health Mysteries

Over 275 Million Genetic Variants Unlock the Key to Health Mysteries

Researchers from the National Institutes of Health (NIH), US have identified over 275 million genetic variants that were not previously reported. This undiscovered pool of variants opens up new avenues for comprehending the genetic factors impacting ...

More Genetics & Stem Cells News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.